Shaun Carter
Nessuna posizione attualmente
Profilo
Shaun Carter worked as a Group Development & Strategy Director at Intersect ENT, Inc. and as a Director-Group Development & Strategy at Carillion Plc.
He holds an MBA from Warwick Business School.
Precedenti posizioni note di Shaun Carter
| Società | Posizione | Fine |
|---|---|---|
| CARILLION PLC | Corporate Officer/Principal | 31/12/2017 |
| INTERSECT ENT, INC. | Corporate Officer/Principal | - |
Formazione di Shaun Carter
| Warwick Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARILLION PLC | Industrial Services |
| Aziende private | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
- Borsa valori
- Insiders
- Shaun Carter
